The SOUL trial showed that oral semaglutide was safe in patients with type 2 diabetes and atherosclerotic cardiovascular ...

Semaglutide, which is traditionally a treatment for type 2 diabetes, was given to participants who had been diagnosed with a life-threatening form of liver disease called metabolic dysfunction ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide, which ...

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

The prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to ...

Semaglutide is the active ingredient in the weight loss medication Wegovy and the diabetes drugs Ozempic and Rybelsus, which are sometimes taken off-label for weight loss. Some pharmacies also ...

We want you to take advantage of everything Clinical Advisor has to offer. To view unlimited content, log in or register for free.

Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which ...